-
1
-
-
33645830172
-
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
-
Juliano RL, Ling VA. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152-62.
-
(1976)
Biochim Biophys Acta
, vol.455
, pp. 152-162
-
-
Juliano, R.L.1
Ling, V.A.2
-
2
-
-
0034724324
-
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
-
Hoffmeyer S, Burk O, von Richter O et.al. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000; 97: 3473-8.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 3473-3478
-
-
Hoffmeyer, S.1
Burk, O.2
von Richter, O.3
-
3
-
-
18144370731
-
Mechanisms of resistance to anticancer drugs: The role of the polymorphic ABC transporters ABCB1 and ABCG2
-
Lepper ER, Nooter K, Verweij J, Acharya MR, Figg WD, Sparreboom A. Mechanisms of resistance to anticancer drugs: The role of the polymorphic ABC transporters ABCB1 and ABCG2. Pharmacogenomics 2005; 6: 115-38.
-
(2005)
Pharmacogenomics
, vol.6
, pp. 115-138
-
-
Lepper, E.R.1
Nooter, K.2
Verweij, J.3
Acharya, M.R.4
Figg, W.D.5
Sparreboom, A.6
-
4
-
-
3042767682
-
Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1
-
Pauli-Magnus C, Kroetz DL. Functional implications of genetic polymorphisms in the multidrug resistance gene MDR1 (ABCB1). Pharm Res 2004; 21: 904-13.
-
(2004)
Pharm Res
, vol.21
, pp. 904-913
-
-
Pauli-Magnus, C.1
Kroetz, D.L.2
-
5
-
-
12444273301
-
MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects
-
Morita Y, Sakaeda T, Horinouchi M et.al. MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects. Pharm Res 2003; 20: 552-6.
-
(2003)
Pharm Res
, vol.20
, pp. 552-556
-
-
Morita, Y.1
Sakaeda, T.2
Horinouchi, M.3
-
6
-
-
0038106665
-
Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs
-
Sakaeda T, Nakamura T, Okumura K. Pharmacogenetics of MDR1 and its impact on the pharmacokinetics and pharmacodynamics of drugs. Pharmacogenomics 2003; 4: 397-410.
-
(2003)
Pharmacogenomics
, vol.4
, pp. 397-410
-
-
Sakaeda, T.1
Nakamura, T.2
Okumura, K.3
-
7
-
-
3042772026
-
Identification of functionally variant MDR1 alleles among European Americans and African Americans
-
Kim RB, Leake BF, Choo EF et.al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 2001; 70: 189-99.
-
(2001)
Clin Pharmacol Ther
, vol.70
, pp. 189-199
-
-
Kim, R.B.1
Leake, B.F.2
Choo, E.F.3
-
8
-
-
0035999902
-
MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine
-
Drescher S, Schaeffeler E, Hitzl M et.al. MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine. Br J Clin Pharmacol 2002; 53: 526-34.
-
(2002)
Br J Clin Pharmacol
, vol.53
, pp. 526-534
-
-
Drescher, S.1
Schaeffeler, E.2
Hitzl, M.3
-
9
-
-
7944236606
-
A variant 2677A allele of the MDR1 gene affects fexofenadine disposition
-
Yi SY, Hong KS, Lim HS et.al. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition. Clin Pharmacol Ther 2004; 76: 418-27.
-
(2004)
Clin Pharmacol Ther
, vol.76
, pp. 418-427
-
-
Yi, S.Y.1
Hong, K.S.2
Lim, H.S.3
-
10
-
-
18144399975
-
Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation
-
Szekeres T, Haushofer A. Clinical pharmacogenetics of immunosuppressive drugs in organ transplantation. Pharmacogenomics 2005; 6: 163-8.
-
(2005)
Pharmacogenomics
, vol.6
, pp. 163-168
-
-
Szekeres, T.1
Haushofer, A.2
-
11
-
-
21444449731
-
ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation
-
Hauser IA, Schaeffeler E, Gauer S et.al. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation. J Am Soc Nephrol 2005; 16: 1501-11.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 1501-1511
-
-
Hauser, I.A.1
Schaeffeler, E.2
Gauer, S.3
-
12
-
-
33749989048
-
MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells
-
Salama NN, Yang Z, Bui T, Ho RJ. MDR1 haplotypes significantly minimize intracellular uptake and transcellular P-gp substrate transport in recombinant LLC-PK1 cells. J Pharm Sci 2006; 95: 2293-308.
-
(2006)
J Pharm Sci
, vol.95
, pp. 2293-2308
-
-
Salama, N.N.1
Yang, Z.2
Bui, T.3
Ho, R.J.4
-
13
-
-
3042600927
-
Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms
-
Meissner K, Jedlitschky G, Meyer zu Schwabedissen H et.al. Modulation of multidrug resistance P-glycoprotein 1 (ABCB1) expression in human heart by hereditary polymorphisms. Pharmacogenetics 2004; 14: 381-5.
-
(2004)
Pharmacogenetics
, vol.14
, pp. 381-385
-
-
Meissner, K.1
Jedlitschky, G.2
Meyer zu Schwabedissen, H.3
-
14
-
-
11144358432
-
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation
-
Anglicheau D, Thervet E, Etienne I et.al. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin Pharmacol Ther 2004; 75: 422-33.
-
(2004)
Clin Pharmacol Ther
, vol.75
, pp. 422-433
-
-
Anglicheau, D.1
Thervet, E.2
Etienne, I.3
-
15
-
-
0037330517
-
Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients
-
Chowbay B, Cumaraswamy S, Cheung YB, Zhou Q, Lee EJ. Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients. Pharmacogenetics 2003; 13: 89-95.
-
(2003)
Pharmacogenetics
, vol.13
, pp. 89-95
-
-
Chowbay, B.1
Cumaraswamy, S.2
Cheung, Y.B.3
Zhou, Q.4
Lee, E.J.5
-
16
-
-
10744222684
-
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
-
Kroetz DL, Pauli-Magnus C, Hodges LM et.al. Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics 2003; 13: 481-94.
-
(2003)
Pharmacogenetics
, vol.13
, pp. 481-494
-
-
Kroetz, D.L.1
Pauli-Magnus, C.2
Hodges, L.M.3
-
17
-
-
0036881149
-
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene
-
Johne A, Köpke K, Gerloff T et.al. Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene. Clin Pharmacol Ther 2002; 72: 584-94.
-
(2002)
Clin Pharmacol Ther
, vol.72
, pp. 584-594
-
-
Johne, A.1
Köpke, K.2
Gerloff, T.3
-
18
-
-
0036693051
-
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein
-
Kurata Y, Ieiri I, Kimura M et.al. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein. Clin Pharmacol Ther 2002; 72: 209-19.
-
(2002)
Clin Pharmacol Ther
, vol.72
, pp. 209-219
-
-
Kurata, Y.1
Ieiri, I.2
Kimura, M.3
-
19
-
-
11344272181
-
Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer
-
Wong M, Evans S, Rivory LP et.al. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer. Clin Pharmacol Ther 2005; 77: 33-42.
-
(2005)
Clin Pharmacol Ther
, vol.77
, pp. 33-42
-
-
Wong, M.1
Evans, S.2
Rivory, L.P.3
-
20
-
-
0035870289
-
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues
-
Maliepaard M, Scheffer GL, Faneyte IF et.al. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 2001; 61: 3458-64.
-
(2001)
Cancer Res
, vol.61
, pp. 3458-3464
-
-
Maliepaard, M.1
Scheffer, G.L.2
Faneyte, I.F.3
-
21
-
-
0034795256
-
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype
-
Zhou S, Schuetz JD, Bunting KD et.al. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001; 7: 1028-34.
-
(2001)
Nat Med
, vol.7
, pp. 1028-1034
-
-
Zhou, S.1
Schuetz, J.D.2
Bunting, K.D.3
-
22
-
-
0032895533
-
Molecular cloning of cDNAs which is highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes
-
Miyake K, Mickley L, Litman T et.al. Molecular cloning of cDNAs which is highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes. Cancer Res 1999; 59: 8-13.
-
(1999)
Cancer Res
, vol.59
, pp. 8-13
-
-
Miyake, K.1
Mickley, L.2
Litman, T.3
-
23
-
-
0034817098
-
Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells
-
Kawabata S, Oka M, Shiozawa K et.al. Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun 2001; 280: 1216-23.
-
(2001)
Biochem Biophys Res Commun
, vol.280
, pp. 1216-1223
-
-
Kawabata, S.1
Oka, M.2
Shiozawa, K.3
-
24
-
-
0037218382
-
Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors
-
Wang X, Furukawa T, Nitanda T et.al. Breast cancer resistance protein (BCRP/ABCG2) induces cellular resistance to HIV-1 nucleoside reverse transcriptase inhibitors. Mol Pharmacol 2003; 63: 65-72.
-
(2003)
Mol Pharmacol
, vol.63
, pp. 65-72
-
-
Wang, X.1
Furukawa, T.2
Nitanda, T.3
-
25
-
-
0036598543
-
C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance
-
Imai Y, Nakane M, Kage K et.al. C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance. Mol Cancer Ther 2002; 1: 611-6.
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 611-616
-
-
Imai, Y.1
Nakane, M.2
Kage, K.3
-
26
-
-
3042651340
-
Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype
-
Sparreboom A, Gelderblom H, Marsh S et.al. Diflomotecan pharmacokinetics in relation to ABCG2 421C>A genotype. Clin Pharmacol Ther 2004; 76: 38-44.
-
(2004)
Clin Pharmacol Ther
, vol.76
, pp. 38-44
-
-
Sparreboom, A.1
Gelderblom, H.2
Marsh, S.3
-
27
-
-
17144413348
-
Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer
-
Zhou Q, Sparreboom A, Tan EH et.al. Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer. Br J Clin Pharmacol 2005; 59: 415-24.
-
(2005)
Br J Clin Pharmacol
, vol.59
, pp. 415-424
-
-
Zhou, Q.1
Sparreboom, A.2
Tan, E.H.3
-
28
-
-
0037038407
-
Determination of doxorubicin and its metabolites in rat serum and bile by LC: Application to preclinical pharmacokinetic studies
-
Zhou Q, Chowbay B. Determination of doxorubicin and its metabolites in rat serum and bile by LC: Application to preclinical pharmacokinetic studies. J Pharm Biomed Anal 2002; 30: 1063-74.
-
(2002)
J Pharm Biomed Anal
, vol.30
, pp. 1063-1074
-
-
Zhou, Q.1
Chowbay, B.2
-
30
-
-
34547788826
-
Role of UGT1A1*6, UGT1A1*28 and ABCG2 c. 421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients
-
Jada SR, Lim R, Wong CI et.al. Role of UGT1A1*6, UGT1A1*28 and ABCG2 c. 421C>A polymorphisms in irinotecan-induced neutropenia in Asian cancer patients. Cancer Sci 2007; 98: 1461-7.
-
(2007)
Cancer Sci
, vol.98
, pp. 1461-1467
-
-
Jada, S.R.1
Lim, R.2
Wong, C.I.3
-
31
-
-
25144433260
-
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C4T affects mRNA stability
-
Wang D, Johnson AD, Papp AC, Kroetz DL, Sadee W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C4T affects mRNA stability. Pharmacogenet Genomics 2005; 15: 693-704.
-
(2005)
Pharmacogenet Genomics
, vol.15
, pp. 693-704
-
-
Wang, D.1
Johnson, A.D.2
Papp, A.C.3
Kroetz, D.L.4
Sadee, W.5
-
32
-
-
0024362996
-
P-glycoprotein gene (MDR1) cDNA from human adrenal: Normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance
-
Kioka N, Tsubota J, Kakehi Y et.al. P-glycoprotein gene (MDR1) cDNA from human adrenal: Normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance. Biochem Biophys Res Commun 1989; 162: 224-31.
-
(1989)
Biochem Biophys Res Commun
, vol.162
, pp. 224-231
-
-
Kioka, N.1
Tsubota, J.2
Kakehi, Y.3
-
33
-
-
0036731995
-
MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients
-
Illmer T, Schuler US, Thiede C et.al. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients. Cancer Res 2002; 62: 4955-62.
-
(2002)
Cancer Res
, vol.62
, pp. 4955-4962
-
-
Illmer, T.1
Schuler, U.S.2
Thiede, C.3
-
34
-
-
33846504706
-
A 'silent' polymorphism in the MDR1 gene changes substrate specificity
-
Kimchi-Sarfaty C, Oh JM, Kim IW et.al. A 'silent' polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315: 525-8.
-
(2007)
Science
, vol.315
, pp. 525-528
-
-
Kimchi-Sarfaty, C.1
Oh, J.M.2
Kim, I.W.3
-
35
-
-
12144286615
-
Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan
-
Sai K, Kaniwa N, Itoda M et.al. Haplotype analysis of ABCB1/MDR1 blocks in a Japanese population reveals genotype-dependent renal clearance of irinotecan. Pharmacogenetics 2003; 13: 741-57.
-
(2003)
Pharmacogenetics
, vol.13
, pp. 741-757
-
-
Sai, K.1
Kaniwa, N.2
Itoda, M.3
-
36
-
-
41349119954
-
Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism
-
October 9: [Epub ahead of print]
-
Rodríguez-Antona C, Niemi M, Backman JT et.al. Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism. Pharmacogenomics J 2007 October 9: [Epub ahead of print].
-
(2007)
Pharmacogenomics J
-
-
Rodríguez-Antona, C.1
Niemi, M.2
Backman, J.T.3
-
37
-
-
19944399722
-
Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta
-
Kobayashi D, Ieiri I, Hirota T et.al. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos 2005; 33: 94-101.
-
(2005)
Drug Metab Dispos
, vol.33
, pp. 94-101
-
-
Kobayashi, D.1
Ieiri, I.2
Hirota, T.3
-
38
-
-
4444381535
-
ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition
-
de Jong FA, Marsh S, Mathijssen RH et.al. ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition. Clin Cancer Res 2004; 10: 5889-94.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 5889-5894
-
-
de Jong, F.A.1
Marsh, S.2
Mathijssen, R.H.3
-
39
-
-
34250825286
-
Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer
-
Han JY, Lim HS, Yoo YK et.al. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer. Cancer 2007; 110: 138-47.
-
(2007)
Cancer
, vol.110
, pp. 138-147
-
-
Han, J.Y.1
Lim, H.S.2
Yoo, Y.K.3
-
40
-
-
34250644339
-
Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients
-
Lal S, Wong ZW, Jada SR et.al. Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients. Pharmacogenomics 2007; 6: 567-75.
-
(2007)
Pharmacogenomics
, vol.6
, pp. 567-575
-
-
Lal, S.1
Wong, Z.W.2
Jada, S.R.3
-
41
-
-
20144364789
-
ABCB5 -mediated doxorubicin transport and chemoresistance in human malignant melanoma
-
Frank NY, Margaryan A, Huang Y et.al. ABCB5 -mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res 2005; 65: 4320-33.
-
(2005)
Cancer Res
, vol.65
, pp. 4320-4333
-
-
Frank, N.Y.1
Margaryan, A.2
Huang, Y.3
-
42
-
-
20044383925
-
The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites
-
Pratt S, Shepard RL, Kandasamy RA, Johnston PA, Perry W 3rd, Dantzig AH. The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther 2005; 4: 855-63.
-
(2005)
Mol Cancer Ther
, vol.4
, pp. 855-863
-
-
Pratt, S.1
Shepard, R.L.2
Kandasamy, R.A.3
Johnston, P.A.4
Perry III, W.5
Dantzig, A.H.6
-
43
-
-
0034622633
-
Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin
-
Awasthi S, Cheng J, Singhal SS et.al. Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. Biochemistry 2000; 39: 9327-34.
-
(2000)
Biochemistry
, vol.39
, pp. 9327-9334
-
-
Awasthi, S.1
Cheng, J.2
Singhal, S.S.3
-
44
-
-
0028081258
-
Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells
-
Slapak CA, Mizunuma N, Kufe DW. Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood 1994; 84: 3113-21.
-
(1994)
Blood
, vol.84
, pp. 3113-3121
-
-
Slapak, C.A.1
Mizunuma, N.2
Kufe, D.W.3
-
45
-
-
0035918322
-
Identification of an amino acid residue in multidrug resistance protein 1 critical for conferring resistance to anthracyclines
-
Zhang DW, Cole SP, Deeley RG. Identification of an amino acid residue in multidrug resistance protein 1 critical for conferring resistance to anthracyclines. J Biol Chem 2001; 276: 13231-9.
-
(2001)
J Biol Chem
, vol.276
, pp. 13231-13239
-
-
Zhang, D.W.1
Cole, S.P.2
Deeley, R.G.3
-
46
-
-
0017258828
-
Adriamycin metabolism in man. Evidence from urinary metabolites
-
Takanashi S, Bachur NR. Adriamycin metabolism in man. Evidence from urinary metabolites. Drug Metab Dispos 1976; 4: 79-87.
-
(1976)
Drug Metab Dispos
, vol.4
, pp. 79-87
-
-
Takanashi, S.1
Bachur, N.R.2
-
47
-
-
34249009348
-
A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity
-
Gonzalez-Covarrubias V, Ghosh D, Lakhman SS, Pendyala L, Blanco JG. A functional genetic polymorphism on human carbonyl reductase 1 (CBR1 V88I) impacts on catalytic activity and NADPH binding affinity. Drug Metab Dispos 2007; 35: 973-80.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 973-980
-
-
Gonzalez-Covarrubias, V.1
Ghosh, D.2
Lakhman, S.S.3
Pendyala, L.4
Blanco, J.G.5
-
48
-
-
13544253732
-
Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3)
-
Lakhman SS, Ghosh D, Blanco JG. Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3). Drug Metab Dispos 2005; 33: 254-7.
-
(2005)
Drug Metab Dispos
, vol.33
, pp. 254-257
-
-
Lakhman, S.S.1
Ghosh, D.2
Blanco, J.G.3
|